Please login to the form below

Not currently logged in
Email:
Password:

Jeff Jonker joins Theravance

He has experience at Genentech
Theravance Jeff Jonker

Theravance has appointed Jeff Jonker as senior VP, corporate and business development.

He joins the US-based biopharma from Satori where he served as chief business officer.

In his new role, he will report to Theravance CEO Rick Winningham and will hold responsibility for managing the company's business and corporate development affairs.

Prior to joining Satori, Jonker held senior roles at Genentech and Gloucester Pharmaceuticals.

"Jeff brings a wealth of industry and deal experience to Theravance,” said Winningham.

The CEO also commented that Jonkers' appointment will support the companys' plans to split into two biotech groups as its deals with GlaxoSmithKline are advanced.

“As Theravance separates into two companies, Jeff's track record of building successful companies and establishing strong collaborations will be important to our future growth,” said Winningham.

4th November 2013

From: Research, Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national...

Latest intelligence

Is communication failing us?
Compelling people to care in a world oversaturated with news and information...
Are your field teams ready to excel in the new era?
A qualitative research approach to help you critically assess post-pandemic learnings and ignite the potential of meaningful interactions with HCPs....
5 Healthcare Marketing Blunders | How To Avoid Them.
Here are 5 healthcare marketing blunders and how best to avoid them....